Cargando…

Can Circulating Regulatory T Cells Predict Cardiovascular Disease?

Detalles Bibliográficos
Autor principal:	Björkbacka, Harry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049994/ https://www.ncbi.nlm.nih.gov/pubmed/27592599 http://dx.doi.org/10.1016/j.ebiom.2016.08.044

Ejemplares similares

Can Antibodies Protect Us Against Cardiovascular Disease?
por: Nilsson, Jan
Publicado: (2016)

Teaching an Old Drug New Tricks: Can Paroxetine Ease the Burden of Cardiovascular Disease in Diabetes?
por: Wheatcroft, Stephen B.
Publicado: (2013)

An important resource and analytic platform for human and mouse cardiovascular-related cis-regulatory elements
por: Xie, Longxiang, et al.
Publicado: (2023)

Predicting Kidney Failure, Cardiovascular Disease and Death in Advanced CKD Patients
por: Naimark, David Malcolm Joseph
Publicado: (2022)

Circulating cytokines in predicting development of severe acute pancreatitis
por: Rotstein, Ori D
Publicado: (2014)

Regulatory RNA Editing Sites in Cancer: Prediction and Beyond
por: Ruan, Hang, et al.
Publicado: (2017)

Can abscopal effects of local radiotherapy be predicted by modeling T cell trafficking?
por: Demaria, Sandra, et al.
Publicado: (2016)

The predictive utility of circulating PCSK9 levels on diabetes mellitus
por: Peng, Jia, et al.
Publicado: (2021)

Regulatory T cells in COVID-19
por: Wang, Huan, et al.
Publicado: (2021)

Can Circulating Tumor DNA Support a Successful Screening Test for Early Cancer Detection? The Grail Paradigm
por: Pons-Belda, Oscar D., et al.
Publicado: (2021)

Circulating cytokines and outcome prediction of burned children with concomitant inhalation injury
por: Myrianthefs, Pavlos M, et al.
Publicado: (2008)

Disease from opposing forces in regulatory control
por: Frank, Steven A
Publicado: (2023)

Differentiation of T Regulatory Cells by Immature Dendritic Cells
por: Roncarolo, Maria-Grazia, et al.
Publicado: (2001)

Cardiovascular medicine in China: what can we do to achieve the Healthy China 2030 plan?
por: Bei, Yihua, et al.
Publicado: (2018)

Cardiovascular Epidemiological Research in China: A Wake-up Call No One Can Afford to Ignore
por: Wei, Xiang, et al.
Publicado: (2021)

The potential of combined mutation sequencing of plasma circulating cell‐free DNA and matched white blood cells for treatment response prediction
por: van der Leest, Paul, et al.
Publicado: (2020)

Revisiting regulatory T cells for stroke therapy
por: Lee, Juneyoung, et al.
Publicado: (2022)

Associations of Interleukin-5 With Plaque Development and Cardiovascular Events
por: Knutsson, Anki, et al.
Publicado: (2019)

Can Body Mass Index Predict the Difficulty of Colonoscopy?
por: Kim, Eui Joo, et al.
Publicado: (2016)

Regulatory T Cells and Ocular Graft Versus Host Disease: A Novel Treatment Approach
por: Pishnamaz, Mohammad Reza, et al.
Publicado: (2018)

How Can We Predict Treatment Outcome for Depression?
por: Walter, Martin, et al.
Publicado: (2014)

Cardiovascular Disease and Antiretroviral Therapy
por: Jarwani, Bhavesh
Publicado: (2019)

Circulating Biomarkers for Cardiovascular Disease Risk Prediction in Patients With Cardiovascular Disease
por: Wong, Yuen-Kwun, et al.
Publicado: (2021)

Somatic copy number aberrations detected in circulating tumor DNA can hold diagnostic value for early detection of hepatocellular carcinoma
por: Chatzaki, Ekaterini, et al.
Publicado: (2020)

Mobilization of Regulatory T Cells in Response to Carotid Injury Does Not Influence Subsequent Neointima Formation
por: Saxena, Amit, et al.
Publicado: (2012)

Arterial or Venous: Where Are the Circulating Tumor Cells?
por: Gray, Elin S.
Publicado: (2015)

Advancing regulatory science, advancing regulatory practice
por: Kurz, Xavier
Publicado: (2017)

Regulatory T cells and IL-10 in allergic inflammation
por: Hawrylowicz, Catherine M.
Publicado: (2005)

The kinetics of T regulatory cells in shock: beyond sepsis
por: Christaki, Eirini, et al.
Publicado: (2010)

Addressing the Bias in Cardiovascular Care: Missed & Delayed Diagnosis of Cardiovascular Disease in Women
por: Johnson, Heather M., et al.
Publicado: (2021)

Dry antibiotic pipeline: Regulatory bottlenecks and regulatory reforms
por: Gupta, Sandeep Kumar, et al.
Publicado: (2014)

Infection as a Trigger for Cardiovascular Disease
por: Alpert, Joseph S.
Publicado: (2020)

TP53 mutations on circulating cell-free DNA
por: Pantel, Klaus
Publicado: (2016)

Circulating cancer stem cells: an interesting niche to explore
por: Papaccio, Federica
Publicado: (2020)

Concomitant medications and circulating tumor cells: friends or foes?
por: Di Cosimo, Serena, et al.
Publicado: (2023)

Regulatory T cells and cardiovascular diseases
por: Hu, Wangling, et al.
Publicado: (2023)

Markers of Apoptosis Predict Cardiovascular Outcomes and Point to ‘Response to Injury’ as a Common Pathway Leading to Diabetes and Cardiovascular Events
por: Hartley, Adam, et al.
Publicado: (2018)

Commentary: “A new hope” in patients with Fontan circulation: High-risk Fontan operation can be done, but for “perfect Fontan” we still aim
por: Kotani, Yasuhiro
Publicado: (2021)

Type I regulatory T cells in malaria: of mice and men
por: Nideffer, Jason, et al.
Publicado: (2023)

Targeting inflammation to improve regulatory T cell therapy for immunopathologies
por: Salomon, Benoit L.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gmgkj67s2jnq7bp6ogf4rcrtqn